OSCR

MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression.

Overview

Authors: Yuan Li1, Yujie Li1, Jiaxin Tang1, Xue Kong1,2, Sibai Sun1,2, Wei Wang1,2,3, Haibo Wu1,2,3
  1. Department of Pathology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230036 China
  2. Intelligent Pathology Institute, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230036 China
  3. Department of Pathology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230036 China
Institutions: University of Science and Technology of China (China)
Journal: Clinical and experimental medicine, volume 26, issue 1, article 208
Dates: received 2 January 2026; accepted 10 February 2026; published online 23 March 2026; in print 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1007/s10238-026-02097-4 · PMID 41866561 · PMCID PMC13046654 · OpenAlex W7140059892
Open access: hybrid, a free copy (OpenAlex)
Status: data only (how the code is found and verified)
Categories: genetics / omics (modality), human (organism), mouse (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics, Connectivity
Keywords: Long non-coding RNA MEG3, Tumor angiogenesis, GSCs, Glioblastoma, VGF
MeSH: Brain Neoplasms*, DNA-Binding Proteins*, Glioblastoma*, Neoplastic Stem Cells*, Neovascularization, Pathologic*, RNA, Long Noncoding*, RNA-Binding Proteins*, Animals, Cell Line, Tumor, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Mice, Mice, Nude (* major topic)
Topic: Glioma Diagnosis and Treatment (Oncology, Medicine), according to OpenAlex
Funding: Natural Science Foundation of Anhui Province (2308085MH272); Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM (2023IHM01043); Fundamental Research Funds for the Central Universities (WK9110000042)
Citations: cited by 1 paper (Europe PMC); 43 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • no repository, dataset or request procedure was recognized in it

Read it in the paper: doi.org/10.1007/s10238-026-02097-4.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 5 keywords, 15 MeSH terms, 3 funders, 33 references.

Cite

This paper

Li, Y., Li, Y., Tang, J., Kong, X., Sun, S., Wang, W., & Wu, H. (2026). MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression. Clinical and experimental medicine, 26(1), 208. https://doi.org/10.1007/s10238-026-02097-4

BibTeX

@article{li2026meg3,
author = {Li, Yuan and Li, Yujie and Tang, Jiaxin and Kong, Xue and Sun, Sibai and Wang, Wei and Wu, Haibo},
title = {{MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression}},
journal = {Clinical and experimental medicine},
year = {2026},
month = mar,
volume = {26},
number = {1},
pages = {208},
publisher = {Springer Science+Business Media},
issn = {1591-8890},
doi = {10.1007/s10238-026-02097-4},
url = {https://doi.org/10.1007/s10238-026-02097-4},
pmid = {41866561},
pmcid = {PMC13046654}
}

RIS

TY - JOUR
AU - Li, Yuan
AU - Li, Yujie
AU - Tang, Jiaxin
AU - Kong, Xue
AU - Sun, Sibai
AU - Wang, Wei
AU - Wu, Haibo
TI - MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression
T2 - Clinical and experimental medicine
J2 - Clin Exp Med
PY - 2026
DA - 2026/03/23
VL - 26
IS - 1
SP - 208
SN - 1591-8890
PB - Springer Science+Business Media
DO - 10.1007/s10238-026-02097-4
UR - https://doi.org/10.1007/s10238-026-02097-4
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s10238-026-02097-4",
"type": "article-journal",
"title": "MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression",
"container-title": "Clinical and experimental medicine",
"author": [
{
"family": "Li",
"given": "Yuan"
},
{
"family": "Li",
"given": "Yujie"
},
{
"family": "Tang",
"given": "Jiaxin"
},
{
"family": "Kong",
"given": "Xue"
},
{
"family": "Sun",
"given": "Sibai"
},
{
"family": "Wang",
"given": "Wei"
},
{
"family": "Wu",
"given": "Haibo"
}
],
"container-title-short": "Clin Exp Med",
"volume": "26",
"issue": "1",
"page": "208",
"DOI": "10.1007/s10238-026-02097-4",
"PMID": "41866561",
"PMCID": "PMC13046654",
"ISSN": "1591-8890",
"publisher": "Springer Science+Business Media",
"URL": "https://doi.org/10.1007/s10238-026-02097-4",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
23
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s40478-025-02036-6
Single-cell transcriptome sequencing reveals new epithelial-stromal associated mesenchymal-like subsets in recurrent gliomas.
Journal: Acta neuropathologica communications
In common: NCBI GEO GSE194329, genetics / omics, other condition, mouse, 1 other category
[2] doi:10.1111/cns.14822
Evidences of neurological injury caused by COVID-19 from glioma tissues and glioma organoids.
Journal: CNS neuroscience & therapeutics
In common: NCBI GEO GSE194329, genetics / omics, other condition
[3] doi:10.1002/cam4.70288
New Anti-Angiogenic Therapy for Glioblastoma With the Anti-Depressant Sertraline.
Journal: Cancer medicine
In common: other condition, mouse, 3 references
[4] doi:10.1186/s12967-026-08397-3
FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/IL-6 signaling pathway.
Journal: Journal of translational medicine
In common: other condition, mouse, cellular / molecular, 3 references
[5] doi:10.1038/s12276-026-01801-4 [code]
Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.
Journal: Experimental & molecular medicine
In common: genetics / omics, other condition, mouse, 1 other category, 2 references
[6] doi:10.1038/s41586-024-07493-y [code]
Single-cell atlas of the human brain vasculature across development, adulthood and disease.
Journal: Nature
In common: genetics / omics, other condition, 2 references
[7] doi:10.1038/s41417-022-00582-y
Single-cell RNA sequencing reveals changes in glioma-associated macrophage polarization and cellular states of malignant gliomas with high AQP4 expression.
Journal: Cancer gene therapy
In common: genetics / omics, other condition, cellular / molecular, 2 references
[8] doi:10.1080/10717544.2026.2660007
Angiopep-2-decorated bacterial outer membrane vesicles penetrate the blood-brain barrier for glioblastoma chemo-immunotherapy.
Journal: Drug delivery
In common: other condition, mouse, cellular / molecular, 2 references
[9] doi:10.1111/cas.70014
Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages.
Journal: Cancer science
In common: other condition, mouse, cellular / molecular, 2 references
[10] doi:10.1038/s44321-025-00195-6
Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile.
Journal: EMBO molecular medicine
In common: other condition, mouse, cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.